Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery

被引:1
作者
Qing, Xuemei [1 ,2 ]
He, Lele [1 ,4 ]
Ma, Ying [3 ,5 ]
Zhang, Yong [1 ,3 ]
Zheng, Wenxin [6 ]
机构
[1] Southwest Med Univ, Dept Obstet & Gynecol, Luzhou 646000, Sichuan, Peoples R China
[2] Qingbaijiang Dist Peoples Hosp, Dept Obstet & Gynecol, Chengdu 610300, Sichuan, Peoples R China
[3] Mianyang Cent Hosp, Dept Obstet & Gynecol, Mianyang 621000, Sichuan, Peoples R China
[4] Chongzhou Maternal & Child Hlth Care Hosp, Dept Obstet & Gynecol, Chengdu 611200, Sichuan, Peoples R China
[5] Chengdu Med Coll, Dept Obstet & Gynecol, Chengdu 610500, Sichuan, Peoples R China
[6] Univ Texas Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dept Obstet & Gynecol, Dept Pathol, Dallas, TX 75390 USA
关键词
Endometriosis; Conservative surgery; GnRH-a; Pregnancy rate; STAGE-III-IV; OVARIAN RESPONSIVENESS; LAPAROSCOPIC SURGERY; EXPECTANT MANAGEMENT; THERAPY; RECURRENCE; INFERTILITY; DIENOGEST; DISEASE; IMPACT;
D O I
10.1186/s12884-024-06430-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Endometriosis frequently results in pain and infertility. While conservative surgery offers some relief, it often falls short of ensuring satisfactory pregnancy outcomes. Adjuvant GnRH-a is administered post-surgery to mitigate recurrence; however, its impact on pregnancy outcomes remains debated. This study endeavors to assess the efficacy of adjuvant GnRH-a in enhancing pregnancy outcomes post-conservative surgery in endometriosis patients. Methods Databases including PubMed, Embase, the Cochrane Library, Medline (Ovid), Web of Science, and Scopus were rigorously searched up to 02 August 2023, without linguistic constraints. Identified articles were screened using strict inclusion and exclusion criteria. Evaluated outcomes encompassed pregnancy rate, live birth rate, miscarriage rate, ectopic pregnancy rate, multiple pregnancy rate, mean postoperative pregnancy interval, recurrence rate, and adverse reaction rate. The Cochrane risk of bias tool and the Jadad score evaluated the included studies' quality. Subgroup and sensitivity analysis were implemented to analyze the pooled results. A meta-analysis model expressed results as standardized mean difference (SMD) and Risk ratio (RR). Results A total of 17 studies about 2485 patients were assimilated. Meta-analysis revealed that post-surgery, the GnRH-a cohort experienced a marginally elevated pregnancy rate (RR = 1.20, 95% CI = 1.02-1.41; P = 0.03) and a reduced mean time to conceive (RR = -1.17, 95% CI = -1.70- -0.64; P < 0.0001). Contrarily, other evaluated outcomes did not exhibit notable statistical differences. Conclusions Incorporating adjuvant GnRH-a following conservative surgery may be deemed beneficial for women with endometriosis, especially before Assisted Reproductive Technology (ART). Nonetheless, owing to pronounced heterogeneity, subsequent research is warranted to substantiate these potential advantages conclusively.
引用
收藏
页数:16
相关论文
共 69 条
  • [1] Clinical diagnosis of endometriosis: a call to action
    Agarwal, Sanjay K.
    Chapron, Charles
    Giudice, Linda C.
    Laufer, Marc R.
    Leyland, Nicholas
    Missmer, Stacey A.
    Singh, Sukhbir S.
    Taylor, Hugh S.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (04) : 354.e1 - 354.e12
  • [2] The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies
    Alborzi, Saeed
    Sorouri, Ziba Zahiri
    Askari, Elham
    Poordast, Tahereh
    Chamanara, Kefayat
    [J]. REPRODUCTIVE MEDICINE AND BIOLOGY, 2019, 18 (04) : 312 - 322
  • [3] A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis
    Alborzi, Saeed
    Hamedi, Bahareh
    Omidvar, Azizeh
    Dehbashi, Sedigheh
    Alborzi, Soroosh
    Alborzi, Mehrnoosh
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 284 (01) : 105 - 110
  • [4] Combined Surgical and Hormone Therapy for Endometriosis is the Most Effective Treatment: Prospective, Randomized, Controlled Trial
    Alkatout, Ibrahim
    Mettler, Liselotte
    Beteta, Carmen
    Hedderich, Juergen
    Jonat, Walter
    Schollmeyer, Thoralf
    Salmassi, Ali
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2013, 20 (04) : 473 - 481
  • [5] Laparoscopic surgery for endometriosis
    Bafort, Celine
    Beebeejaun, Yusuf
    Tomassetti, Carla
    Bosteels, Jan
    Duffy, James M. N.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (10):
  • [6] The Role of GnRH Analogues in Improving Outcome in Women Undergoing Superovulation and Intrauterine Insemination after Surgical Correction of Mild Endometriosis: A Randomized Controlled Trial
    Bansal, Piyush
    Khoiwal, Kavita
    Malhotra, Neena
    Dadhwal, Vatsla
    Sharma, Aparna
    Deka, Dipika
    [J]. EURASIAN JOURNAL OF MEDICINE, 2018, 50 (02) : 105 - 110
  • [7] ESHRE guideline: endometriosis
    Becker, Christian M.
    Bokor, Attila
    Heikinheimo, Oskari
    Horne, Andrew
    Jansen, Femke
    Kiesel, Ludwig
    King, Kathleen
    Kvaskoff, Marina
    Nap, Annemiek
    Petersen, Katrine
    Saridogan, Ertan
    Tomassetti, Carla
    van Hanegem, Nehalennia
    Vulliemoz, Nicolas
    Vermeulen, Nathalie
    [J]. HUMAN REPRODUCTION OPEN, 2022, 2022 (02)
  • [8] Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy
    Bedaiwy, Mohamed A.
    Allaire, Catherine
    Alfaraj, Sukinah
    [J]. FERTILITY AND STERILITY, 2017, 107 (03) : 537 - 548
  • [9] Safety of medical treatments for endometriosis
    Berlanda, Nicola
    Somigliana, Edgardo
    Vigano, Paola
    Vercellini, Paolo
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (01) : 21 - 30
  • [10] Emerging gonadotropin-releasing hormone agonists
    Beyer, Daniel Alexander
    Amari, Feriel
    Thill, Marc
    Schultze-Mosgau, Askan
    Al-Hasani, Safaa
    Diedrich, Klaus
    Griesinger, Georg
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (02) : 323 - 340